Journal article
The importance of considering competing treatment affecting prognosis in the evaluation of therapy in trials: the example of renal transplantation in hemodialysis trials.
- Abstract:
-
Background: During the follow-up in a randomized controlled trial (RCT), participants may receive additional (non-randomly allocated) treatment that affects the outcome. Typically such additional treatment is not taken into account in evaluation of the results. Two pivotal trials of the effects of hemodiafiltration (HDF) versus hemodialysis (HD) on mortality in patients with end-stage renal disease reported differing results. We set out to evaluate to what extent methods to take other treatm...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
EuDial
More from this funder
Bibliographic Details
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- Nephrology Dialysis Transplantation Journal website
- Volume:
- 32
- Issue:
- S2
- Pages:
- ii31-ii39
- Publication date:
- 2017-02-27
- Acceptance date:
- 2016-12-20
- DOI:
- EISSN:
-
1460-2385
- ISSN:
-
0931-0509
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:689331
- UUID:
-
uuid:a9857cdb-7241-4973-ae00-af1a1fab9cf5
- Local pid:
- pubs:689331
- Source identifiers:
-
689331
- Deposit date:
- 2017-08-11
Terms of use
- Copyright holder:
- Hazelbag et al
- Copyright date:
- 2017
- Notes:
- © The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. This is the accepted manuscript version of the article. The final version is available online from Oxford University Press at: 10.1093/ndt/gfw458
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record